Olaparib is indicated for the treatment of certain types of ovarian, breast, pancreatic, and prostate cancers in patients who have specific genetic mutations, specifically in…

Earnings before interest, tax, depreciation, and amortisation (EBITDA) rose to ₹266.8 crore from ₹124.1 crore a year ago, while the EBITDA margin expanded to 18.6%…

Revenue for the quarter grew 63.7% year-on-year to ₹516 crore from ₹315.2 crore in Q2 FY25. Earnings before interest, tax, depreciation, and amortisation (EBITDA) increased…

Global Health Ltd reported a 21% YoY rise in Q2 net profit to ₹158.4 crore, driven by steady revenue growth of nearly 15% to ₹1,099…

Puravankara reported sales of ₹1,322 crore in Q2 FY26, up 4% year-on-year, on a sales volume of 1.5 million square feet. Average sales realisation rose…

Shares of the company ended at a price of ₹560.95 on the BSE, 0.5% higher than the last closing price. The stock is down 25.3%…

Markets regulator Sebi on Friday came out with a draft circular to clarify operational aspects of maintaining prorata and paripassu rights of investors in alternative…

The company’s net profit rose to ₹152.7 crore for the quarter ended Sept 30, from ₹136.3 crore a year earlier.

The Chennai-based water technology company’s revenue from operations grew 19.2% to ₹834 crore from ₹700 crore a year earlier, supported by project execution both in…

Petronet LNG’s board of directors declared an interim dividend of ₹7 per share on the equity shares of the company for the financial year 2025-26.…